MoonLake Immunotherapeuti... (MLTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
45.15
0.26 (0.58%)
At close: Jan 28, 2025, 3:02 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -82.39 | -4.78 | -1.45 | -1.85K |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 5.98 | 6.30 | -6.66 | 1.50 |
P/FCF Ratio | -68.89 | -5.51 | -2.2 | -531.53 |
P/OCF Ratio | -69.35 | -5.52 | -2.2 | -531.53 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | -1.29 | 0.00 |
Quick Ratio | 51.59 | 9.98 | 0.39 | 12.93 |
Current Ratio | 51.59 | 9.98 | 0.46 | 12.93 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.07 | -1.32 | 4.61 | -0.00 |
Return on Assets (ROA) | -0.07 | -0.84 | -5.54 | -0.00 |
Return on Capital (ROIC) | -0.1 | -0.94 | 4.70 | -0.00 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |